Valuation: Abbott Laboratories

Market Cap 183B 159B 149B 136B 257B 17,425B 260B 1,739B 682B 8,706B 687B 672B 28,977B P/E 2026 *
30.3x
P/E 2027 * 23.3x
Enterprise Value 207B 180B 168B 154B 291B 19,727B 294B 1,969B 773B 9,856B 778B 761B 32,805B EV / Sales 2026 *
4.12x
EV / Sales 2027 * 3.74x
Free-Float
86.16%
Yield 2026 *
2.43%
Yield 2027 * 2.57%
1 day+1.75%
1 week+1.94%
Current month+1.85%
1 month+12.58%
3 months+24.75%
6 months-2.86%
Current year-14.07%
1 week 102.89
Extreme 102.89
109.33
1 month 87.64
Extreme 87.64
110.04
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

416 0.0000%
6/30/26 Free

Director

432 0.0000%
6/30/26 Free

Director

363 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%+1.94%-17.77%-0.73% 183B
+0.15%+0.56%-3.55%+1.74% 110B
+1.65%+3.04%+13.37%+72.42% 61.72B
-1.64%+7.20%+39.25%+56.58% 54.98B
+3.56%+6.80%+2.49%-35.80% 47.02B
-4.68%-10.24% - - 32.16B
+0.56%+11.62%+8.90%-31.22% 31.19B
-1.05%+2.21%+46.28%-8.35% 24.7B
-0.91%-0.37%+4.13%+1.84% 22.68B
+1.05%-2.96%-9.30%+5.31% 21.42B
Average +0.04%+0.86%+9.31%+6.87% 58.89B
Weighted average by Cap. +0.61%+0.04%+1.39%+8.86%

Financials

2026 *2027 *
Net sales 50.3B 43.65B 40.88B 37.39B 70.59B 4,792B 71.51B 478B 188B 2,394B 189B 185B 7,969B 54.65B 47.42B 44.41B 40.62B 76.69B 5,206B 77.69B 520B 204B 2,601B 205B 201B 8,657B
Net income 6.23B 5.41B 5.06B 4.63B 8.74B 594B 8.86B 59.23B 23.25B 297B 23.39B 22.88B 987B 7.93B 6.89B 6.45B 5.9B 11.13B 756B 11.28B 75.43B 29.6B 378B 29.79B 29.14B 1,257B
Net Debt 24.17B 20.97B 19.64B 17.96B 33.91B 2,302B 34.35B 230B 90.16B 1,150B 90.73B 88.76B 3,828B 21.42B 18.58B 17.4B 15.92B 30.05B 2,040B 30.45B 204B 79.9B 1,019B 80.41B 78.66B 3,393B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-08-06 $107.25 +1.46% 5,655,196
26-08-05 $105.71 +0.24% 9,313,212
26-08-04 $105.46 -1.55% 8,157,066
26-08-03 $107.12 +1.34% 7,409,567
26-07-31 $105.70 +0.09% 9,610,141
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
105.71USD
Average target price
118.42USD
Spread / Average Target
+12.02%

Quarterly revenue - Rate of surprise